|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:abusePotential
|
high
|
|
gptkbp:alternativeTo
|
gptkb:Adderall
gptkb:Ritalin
gptkb:Vyvanse
|
|
gptkbp:approvedBy
|
1937
|
|
gptkbp:ATCCode
|
N06BA02
|
|
gptkbp:brand
|
gptkb:dextroamphetamine
|
|
gptkbp:chemicalClass
|
amphetamine
|
|
gptkbp:contraindication
|
gptkb:cardiovascular_disease
glaucoma
hyperthyroidism
history of drug abuse
|
|
gptkbp:controlledSubstanceSchedule
|
gptkb:Schedule_II_(US)
|
|
gptkbp:countryOfOperation
|
gptkb:Canada
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:discoveredBy
|
gptkb:Smith,_Kline_&_French
|
|
gptkbp:drugInteraction
|
gptkb:tricyclic_antidepressants
gptkb:monoamine_oxidase_inhibitors
antihypertensives
|
|
gptkbp:eliminationHalfLife
|
10-12 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:form
|
gptkb:tablet
extended-release capsule
|
|
gptkbp:genericAvailable
|
yes
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Dexedrine
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
Amedra Pharmaceuticals
|
|
gptkbp:mechanismOfAction
|
increases synaptic concentrations of dopamine and norepinephrine
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:notRecommendedFor
|
children under 3 years
|
|
gptkbp:overdoseSymptoms
|
gptkb:arrhythmia
hypertension
hallucinations
agitation
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:prescribes
|
adults
children
|
|
gptkbp:prescriptionRequired
|
yes
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
anxiety
loss of appetite
increased heart rate
insomnia
dry mouth
|
|
gptkbp:usedFor
|
gptkb:attention_deficit_hyperactivity_disorder
narcolepsy
|
|
gptkbp:bfsParent
|
gptkb:dextroamphetamine
|
|
gptkbp:bfsLayer
|
7
|